Considering that AhR has recently emerged as a physiological regulator of the innate and adaptive immune responses, in a previous publication we described that AFP 464 modulates the immune response in the estrogen-dependent, Tamoxifen-sensitive spontaneous M05 mammary carcinoma model. Here, AFP is linked to breast carcinoma.